Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What is Mohs micrographic surgery? 8 FAQs about Mohs

2.

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

3.

In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.

4.

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

5.

How the skin cancer virus outperforms the replication of host cells.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot